Skip to main content
Clinical Trials/ACTRN12621001527853
ACTRN12621001527853
Recruiting
未知

Specialised Dietary Fibre Intervention in Children with Type 1 Diabetes - is it safe, feasible and tolerable?

Queensland Children's Hospital0 sites30 target enrollmentStarted: November 10, 2021Last updated:

Overview

Phase
未知
Status
Recruiting
Sponsor
Queensland Children's Hospital
Enrollment
30

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
5 Years to 14 Years (—)
Sex
All

Inclusion Criteria

  • Children and adolescents aged 5 – 14 years (inclusive) with T1D that was diagnosed at least 3 months prior to entry into the study
  • \- HbA1c less than or equal to 9% (75 mmol/mol) at the time of entry into the study
  • \- BMI between 15th centile and 85th centile, inclusive
  • \- The child/adolescent and their family are willing and able to follow the study protocol

Exclusion Criteria

  • \- Concomitant disease or treatment that may, in the judgement of the investigators, impact on glycaemic control, insulin requirements or other outcome measures
  • \- Hypoglycaemia unawareness
  • \- History or symptoms of malabsorption or gastrointestinal disease, including coeliac disease
  • \- Known liver or renal disease
  • \- On a restricted or special diet that would impact their ability to take the supplement e.g. intermittent fasting or ketogenic diet
  • \- Use of medication other than insulin that affects glucose homeostasis
  • \- Antibiotic usage within the six weeks prior to entry into the study or anticipated usage during the study

Investigators

Sponsor
Queensland Children's Hospital

Similar Trials